AstraZeneca cancer drug combo meets late-stage trial goal

AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.

from Reuters: Health News https://ift.tt/2WmRIFq
via IFTTT